We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+9.38%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$5B
AUM Growth
-$515M
Cap. Flow
-$868M
Cap. Flow %
-17.36%
Top 10 Hldgs %
42.58%
Holding
90
New
18
Increased
21
Reduced
23
Closed
27

Sector Composition

Rank Sector Weight
1 Healthcare 37.84%
2 Communication Services 11.85%
3 Materials 8.94%
4 Consumer Discretionary 8.09%
5 Technology 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN
1
DELISTED
Allergan Inc
AGN
$276M 5.51%
1,628,870
+888,487
+120% +$138M
RAD
2
DELISTED
Rite Aid Corporation
RAD
$256M 5.12%
1,784,834
+1,496,088
+518% +$221M
VMC icon
3
Vulcan Materials
VMC
$36.4B
$229M 4.59%
3,598,626
+1,916,237
+114% +$121M
HOT
4
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$228M 4.55%
2,815,488
+93,410
+3% +$7.34M
MLM icon
5
Martin Marietta Materials
MLM
$33.2B
$218M 4.36%
1,649,558
+996,297
+153% +$125M
HCA icon
6
HCA Healthcare
HCA
$82.8B
$201M 4.01%
3,557,748
-1,206,080
-25% -$63.6M
WBA
7
DELISTED
Walgreens Boots Alliance
WBA
$185M 3.7%
2,499,165
-343,346
-12% -$24M
TEVA icon
8
Teva Pharmaceuticals
TEVA
$36.5B
$184M 3.69%
3,519,050
+99,697
+3% +$5.1M
NFLX icon
9
Netflix
NFLX
$286B
$179M 3.58%
+28,445,060
New +$154M
AGN
10
DELISTED
Allergan plc
AGN
$174M 3.48%
779,476
-252,666
-24% -$52.3M
MCK icon
11
McKesson
MCK
$97.3B
$162M 3.24%
870,113
+384,046
+79% +$68.3M
TFCFA
12
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$160M 3.2%
4,548,316
+525,631
+13% +$17.9M
BHC icon
13
Bausch Health
BHC
$1.69B
$131M 2.63%
1,042,410
+232,667
+29% +$29.7M
BKNG icon
14
Booking.com
BKNG
$139B
$130M 2.59%
2,696,200
+1,580,650
+142% +$75.9M
ADBE icon
15
Adobe
ADBE
$90.3B
$121M 2.42%
+1,673,246
New +$108M
MDVN
16
DELISTED
MEDIVATION, INC.
MDVN
$117M 2.34%
3,036,834
+2,526,624
+495% +$85.2M
PANW icon
17
Palo Alto Networks
PANW
$279B
$113M 2.26%
+8,076,240
New +$94.3M
A icon
18
Agilent Technologies
A
$37.5B
$107M 2.15%
2,611,598
-197,094
-7% -$7.91M
META icon
19
Meta Platforms (Facebook)
META
$1.63T
$99.8M 1.99%
1,482,536
+885,375
+148% +$54.5M
AAP icon
20
Advance Auto Parts
AAP
$3.14B
$95.4M 1.91%
+707,241
New +$87.6M
GILD icon
21
Gilead Sciences
GILD
$162B
$88.5M 1.77%
1,066,955
-872,877
-45% -$67.9M
MIC
22
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$86.5M 1.73%
1,387,014
+354,284
+34% +$20.9M
SBUX icon
23
Starbucks
SBUX
$119B
$79.8M 1.6%
+2,062,802
New +$74.9M
SAVE
24
DELISTED
Spirit Airlines, Inc.
SAVE
$79.1M 1.58%
1,250,814
+1,231,550
+6,393% +$72.7M
AXP icon
25
American Express
AXP
$239B
$75M 1.5%
790,506
+207,624
+36% +$18.7M

Similar funds

PFM Health Sciences's Q2 2014 Portfolio in Review

As of Q2 2014, PFM Health Sciences held 90 positions worth $5B, down 9.3% from $5.52B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

PFM Health Sciences withdrew a net $868M in Q2 2014, closing 27 positions and reducing 23 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $439M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 46% a quarter earlier, followed by Communication Services and Materials.

Against the trend, PFM Health Sciences opened a new position in Netflix worth $179M.

  • PFM Health Sciences's largest Q2 2014 buy was Netflix: 28,445,060 shares worth $179M.
  • PFM Health Sciences added most to Rite Aid Corporation in Q2 2014, an estimated $221M increase.
  • PFM Health Sciences's biggest Q2 2014 reduction was Alphabet (Google) Class C, cutting an estimated $230M.
  • PFM Health Sciences fully exited iShares MSCI Emerging Markets ETF in Q2 2014, selling an estimated $439M.
  • PFM Health Sciences's ten largest holdings make up 43% of its $5B portfolio in Q2 2014.
  • PFM Health Sciences opened 18 new positions and closed 27 in Q2 2014.
  • PFM Health Sciences's portfolio value fell 9.3% quarter-over-quarter to $5B.

Based on PFM Health Sciences's 13F filing for Q2 2014, filed 14 Aug 2014.